Díaz JC, Weir D, Uribe W, Aristizábal J, Velásquez J, Marin J, Duque M

Idioma: Ingles.
Referencias bibliográficas: 36
Paginas: 171-180
Archivo PDF: 301.69 Kb.

RESUMEN

La fibrilación auricular es la arritmia sostenida más común en la población general, responsable de una gran morbilidad y mortalidad debido a un mayor riesgo de embolia sistémica. Las características hemodinámicas y anatómicas del sistema cardiovascular conducen directamente la mayoría de los émbolos hacia el sistema nervioso central o a la circulación periférica, siendo la embolia coronaria infrecuente. Esto ha llevado a una escasez en la literatura médica sobre la importancia de la fibrilación auricular como causa de infarto agudo de miocardio y del tratamiento que debe ser ofrecido a estos pacientes, con la mayoría de las pruebas derivadas de informes de casos y series de casos pequeñas. Un caso de infarto agudo de miocardio asociado con embolia coronaria en un paciente con fibrilación auricular de nueva aparición que fue tratada exitosamente con tromboaspiración es presentado, seguido de una revisión sistemática del tema. El objetivo de esta revisión es determinar las características clínicas de los pacientes con embolia coronaria debido a fibrilación auricular y determinar las mejores opciones de tratamiento basadas en la evidencia disponible.

REFERENCIAS (EN ESTE ARTÍCULO)

1. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr. et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014; 130: e199-267.

2. European Heart Rhythm A, European Association for Cardio-Thoracic S, Camm AJ Camm AJ, Kirchhof P, Lip GY, Schotten U et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010; 12: 1360-1420.

3. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J. 2007; 28: 2803-2817.

4. Wolf PA, Dawber TR, Thomas HE, Jr., Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978; 28: 973-977.

5. Bekwelem W, Connolly SJ, Halperin JL, Adabag S, Duval S, Chrolavicius S et al. Extracranial systemic embolic events in patients with nonvalvular atrial fibrillation: incidence, risk factors, and outcomes. Circulation. 2015; 132: 796-803.

6. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS et al. Lifetime risk for development of atrial fibrillation: the Framingham heart study. Circulation. 2004; 110: 1042-1046.

7. Richardson PM, Gotsman MS. Angiographic evidence of coronary embolism and resolution. S Afr Med J. 1971; 45: 805-809.

8. Sakai K, Inoue K, Nobuyoshi M. Aspiration thrombectomy of a massive thrombotic embolus in acute myocardial infarction caused by coronary embolism. Int Heart J. 2007; 48: 387-392.

9. Acikel S, Dogan M, Aksoy MM, Akdemir R. Coronary embolism causing non-ST elevation myocardial infarction in a patient with paroxysmal atrial fibrillation: treatment with thrombus aspiration catheter. Int J Cardiol. 2011; 149: e33-35.

10. Zasada W, Bartus S, Krolikowski T, Dudek D. Patient with atrial fibrillation and myocardial infarction due to coronary artery embolism treated with thrombus aspiration. Kardiologia Polska. 2013; 71: 99-101.

11. Kim HL, Seo JB, Chung WY, Zo JH, Kim MA, Kim SH. Simultaneously presented acute ischemic stroke and non-st elevation myocardial infarction in a patient with paroxysmal atrial fibrillation. Korean Circ J. 2013; 43: 766-769.

12. Gagliardi L, Guerbaai RA, Marliere S, Bouvaist H, Ennezat PV. Coronary embolization following electrical cardioversion in a patient treated with dabigatran. Int J Cardiol. 2014; 175: 571-572.

13. Tsang MY, Calvin AD, Reeder GS, Ammash NM, Hammack JE, Melduni RM. New-onset chest pain and palpitation. Coronary embolism. Heart. 2014; 100 (22): 1769, 1814-1815.

14. Mallouppas M, Christopoulos C, Watson W, Cader R, Cooper J. An uncommon complication of atrial fibrillation. Oxford Medical Case Reports. 2015; 2015: 232-234.

15. Van de Walle S, Dujardin K. A case of coronary embolism in a patient with paroxysmal atrial fibrillation receiving tamoxifen. Int J Cardiol. 2007; 123: 66-68.

16. Camaro C, Aengevaeren WR. Acute myocardial infarction due to coronary artery embolism in a patient with atrial fibrillation. Neth Heart J. 2009; 17: 297-299.

17. Garg RK, Jolly N. Acute myocardial infarction secondary to thromboembolism in a patient with atrial fibrillation. Int J Cardiol. 2007; 123: e18-20.

18. Lin TC, Hsieh YC, Lee WL, Lin YK, Ting CT, Wu TJ. Acute embolic myocardial infarction in a patient with paroxysmal atrial fibrillation receiving direct-current cardioversion. J Chin Med Assoc. 2009; 72: 146-149.

19. Pindado J, Marcos-Alberca P, Rey M, Rábago R, de Diego C, Ibáñez B et al. Incomplete myocardial rupture after coronary embolism of an isolated single coronary artery. Eur J Echocardiog. 2005; 6: 72-74.

20. Kotooka N, Otsuka Y, Yasuda S, Morii I, Kawamura A, Miyazaki S. Three cases of acute myocardial infarction due to coronary embolism: Treatment using a thrombus aspiration device. Jpn Heart J. 2004; 45: 861-866.

21. Ilia R, Weinstein JM, Wolak A, Cafri C. Coronary thrombus in ST elevation myocardial infarction and atrial fibrillation. J Thromb Thrombolysis. 2013; 35: 119-122.

22. Hideko H, Dote K, Kato M, Kato M, Sasaki S, Oda N et al. Clinical impact of acute coronary syndrome due to coronary thromboembolism with atrial fibrillation. Circulation. 2013; 128: A16112.

23. Huang A, Shaw E, Hansen P, et al. The impact of aspiration thrombectomy on the diagnosis and outcomes of coronary embolism. Heart Lung and Circulation. 2011; 20: S149.

24. Shibata T, Kawakami S, Noguchi T, Tanaka T, Asaumi Y, Kanaya T et al. Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism. Circulation. 2015; 132: 241-250.

25. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2014; 129: 837-847.

26. Khoo CW, Krishnamoorthy S, Lim HS, Lip GY. Atrial fibrillation, arrhythmia burden and thrombogenesis. Int J Cardiol. 2012; 157: 318-323.

27. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet. 2009; 373: 155-166.

28. Soliman EZ, Safford MM, Muntner P, Khodneva Y, Dawood FZ, Zakai NA et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014; 174: 107-114.

29. Prizel KR, Hutchins GM, Bulkley BH. Coronary artery embolism and myocardial infarction. Ann Intern Med. 1978; 88: 155-161.

30. Daniel M, Ekenback C, Agewall S, Brolin EB, Caidahl K, Cederlund K et al. Risk factors and markers for acute myocardial infarction with angiographically normal coronary arteries. Am J Cardiol. 2015; 116: 838-844.

31. Abid L, Bahloul A, Frikha Z, Mallek S, Abid D, Akrout M et al. Myocardial infarction and normal coronary arteries: the experience of the cardiology department of Sfax, Tunisia. Intern Med. 2012; 51: 1959-1967.

32. Collste O, Sorensson P, Frick M, Agewall S, Daniel M, Henareh L et al. Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study. J Int Medicine. 2013; 273: 189-196.

33. Larsen AI, Nilsen DW, Yu J, Mehran R, Nikolsky E, Lansky AJ et al. Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial). Am J Cardiol. 2013; 111: 643-648.

34. Stensaeth KH, Fossum E, Hoffmann P, Mangschau A, Klow NE. Clinical characteristics and role of early cardiac magnetic resonance imaging in patients with suspected ST-elevation myocardial infarction and normal coronary arteries. Int J Cardiovasc Imaging. 2011; 27: 355-365.

35. Waller BF. Atherosclerotic and nonatherosclerotic coronary artery factors in acute myocardial infarction. Cardiovasc Clin. 1989; 20: 29-104.

36. Varin R, Mirshahi S, Mirshahi P, Klein C, Jamshedov J, Chidiac J et al. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban. Thromb Res. 2013; 131: e100-109.